Our results suggested that the IHC panel consisting of ANO1 and MMP3 can be used as an independent prognostic predictor of ESCC and can divide ESCC patients into three different risk subgroups based on zero, one or two positive markers. Here, MMP3 is linked to esophageal squamous cell carcinoma.